CorMedix CRMD
NASDAQ CRMD
$7.19 -0.23 (-3.10%)
At close: Oct 2, 2026 · 4:00 PM EDT

CorMedix (CRMD) Gains from Investment Securities (2015 - 2019)

Updated

CorMedix's Gains from Investment Securities was $1,009 in Q1 2019.

Analysis

CorMedix (CRMD) Gains from Investment Securities (2015 - 2019) Analysis & Trends

From Q2 2015 onward, CorMedix has reported Gains from Investment Securities for 8 quarters.

  • The Q1 2019 figure marks the highest quarterly Gains from Investment Securities since Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 CorMedix 558.43 Mn -94.09 Mn 77.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 1,009.00
Sep 30, 2017 2,600.00
Jun 30, 2017 300.00
Mar 31, 2017 10,113.00
Sep 30, 2016 -6,764.00
Jun 30, 2016 24,790.00
Mar 31, 2016 -793.00
Jun 30, 2015 -5,504.00
API Access

CorMedix Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=CRMD&period=max&api_key=YOUR_API_KEY